Epidemiologic Characteristics and Natural History of HIV-1 Natural Viral Suppressors

被引:58
作者
Sajadi, Mohammad M. [1 ]
Constantine, Neil T. [1 ]
Mann, Dean L. [2 ]
Charurat, Manhattan [1 ]
Dadzan, Elham [1 ]
Kadlecik, Peter [3 ]
Redfield, Robert R. [1 ]
机构
[1] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA
[3] Chase Brexton Hlth Serv, Baltimore, MD USA
关键词
elite suppressor; elite controller; HIV; natural viral suppressor; natural history; LONG-TERM NONPROGRESSORS; IMMUNODEFICIENCY-VIRUS TYPE-1; ELITE SUPPRESSORS; DISEASE PROGRESSION; IN-VITRO; REPLICATION; INFECTION; SURVIVORS; THERAPY; EXPRESSION;
D O I
10.1097/QAI.0b013e3181945f1e
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: The objective of this study was to detail the epidemiologic characteristics and natural history of HIV-1 natural viral suppressors (NVSs), a cohort of HIV-1-infiected individuals who are able to suppress viral replication to undetectable levels in the absence of therapy. Design and Methods: HIV-1 patients who met the NVS criteria were enrolled into a prospective study. The incidence and prevalence of NVS were calculated by performing a chart review on all patients seen in 1 clinic in a 10-year period. Cumulative probability of progression-free survival was calculated by Kaplan-Meier product limit method. Results: Forty individuals enrolled in the study. The median year of diagnosis was 1994, and individuals demonstrated a median 6.7 years of HIV-1 viral suppression and CD4 count of 795 cells per microliter. NVS had an incidence of 1.1% [95% confidence interval (CI), 0.0 to 2.1] and prevalence of 1.5% (95% CI, 0.8 to 2.1). Only 1 patient (2.5%) has progressed. Within the first 10 years for follow-up having met the definition of NVS, 95.1% (95% CI 86.5% to 100%) of the NVS continued to control their viral loads to undetectable levels. Conclusions: The NVS cohort has demonstrated remarkable stability and a low rate of progression over many years. Detailed evaluations of viral-host immune regulatory factors associated with persistent HIV-1 natural viral suppression, and loss of such suppression, has the potential to provide important new insight in HIV pathogenesis and future immune regulatory targeted preventive and therapeutic research.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 23 条
  • [1] CD4+ T cell depletion in an untreated HIV type1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load
    Andrade, Adriana
    Bailey, Justin R.
    Xu, Jie
    Philp, Frances H.
    Quinn, Thomas C.
    Williams, Thomas M.
    Ray, Stuart C.
    Thomas, David L.
    Blankson, Joel N.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) : E78 - E82
  • [2] Predictors of progression in long-term nonprogressors
    Ashton, LJ
    Carr, A
    Cunningham, PH
    Roggensack, M
    McLean, K
    Law, M
    Robertson, M
    Cooper, DA
    Kaldor, JM
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (02) : 117 - 121
  • [3] Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations
    Bailey, Justin R.
    Williams, Thomas M.
    Siliciano, Robert F.
    Blankson, Joel N.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (05) : 1357 - 1369
  • [4] Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy
    Bailey, Justin R.
    Lassen, Kara G.
    Yang, Hung-Chih
    Quinn, Thomas C.
    Ray, Stuart C.
    Blankson, Joel N.
    Siliciano, Robert F.
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (10) : 4758 - 4770
  • [5] An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC)
    Birch, MR
    Learmont, JC
    Dyer, WB
    Deacon, NJ
    Zaunders, JJ
    Saksena, N
    Cunningham, AL
    Mills, J
    Sullivan, JS
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2001, 22 (03) : 263 - 270
  • [6] Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors
    Blankson, Joel N.
    Bailey, Justin R.
    Thayil, Seema
    Yang, Hung-Chih
    Lassen, Kara
    Lai, Jun
    Gandhi, Shiv K.
    Siliciano, Janet D.
    Williams, Thomas M.
    Siliciano, Robert F.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (05) : 2508 - 2518
  • [7] Candotti D, 1999, J MED VIROL, V58, P256, DOI 10.1002/(SICI)1096-9071(199907)58:3<256::AID-JMV11>3.0.CO
  • [8] 2-Z
  • [9] VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    CAO, YZ
    QIN, LM
    ZHANG, LQ
    SAFRIT, J
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) : 201 - 208
  • [10] In vitro activation of HIV RNA expression in peripheral blood lymphocytes as a marker to predict the stability of non-progressive status in long-term survivors
    Garbuglia, AR
    Salvi, R
    DiCaro, A
    Cappiello, G
    Montella, F
    DiSora, F
    Recchia, O
    Lauria, F
    Benedetto, A
    [J]. AIDS, 1996, 10 (01) : 17 - 21